DEA schedule
Is brivaracetam a controlled substance?
Federal schedule for brivaracetam from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Brivaracetam is a Schedule V controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Brivaracetam (Schedule V).
Run it in Rivvi
Which 2027 plans near you dropped or restricted brivaracetam?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 62 prescription listings from 17 labelers, all Schedule V |
| DEA controlled substances list | Brivaracetam: Schedule V |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Brivaracetam | 2710 | V | No | BRV; UCB-34714; Briviact; ((2S)-2-[(4R)-2-oxo-4- | Listed by name |
Brivaracetam NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 50474-970 | Briviact | injection, suspension | 50 mg/5mL | UCB, Inc. | CV |
| 50474-870 | Briviact | solution | 10 mg/mL | UCB, Inc. | CV |
| 50474-370 | Briviact | tablet, film coated | 10 mg/1 | UCB, Inc. | CV |
| 50474-770 | Briviact | tablet, film coated | 100 mg/1 | UCB, Inc. | CV |
| 50474-470 | Briviact | tablet, film coated | 25 mg/1 | UCB, Inc. | CV |
| 50474-570 | Briviact | tablet, film coated | 50 mg/1 | UCB, Inc. | CV |
| 50474-670 | Briviact | tablet, film coated | 75 mg/1 | UCB, Inc. | CV |
| 0121-1075 | Brivaracetam | injection | 50 mg/5mL | PAI Holdings, LLC dba PAI Pharma | CV |
| 14335-420 | Brivaracetam | injection | 50 mg/5mL | Hainan Poly Pharm. Co., Ltd. | CV |
| 42571-370 | BRIVARACETAM | injection | 50 mg/5mL | Micro Labs Limited | CV |
| 72205-272 | Brivaracetam | injection, solution | 50 mg/5mL | Novadoz Pharmaceuticals LLC | CV |
| 0121-1074 | Brivaracetam | solution | 10 mg/mL | PAI Holdings, LLC dba PAI Pharma | CV |
| 59651-995 | BRIVARACETAM | solution | 10 mg/mL | Aurobindo Pharma Limited | CV |
| 70748-411 | BRIVARACETAM | solution | 10 mg/mL | Lupin Pharmaceuticals, Inc. | CV |
| 72205-033 | brivaracetam | solution | 10 mg/mL | Novadoz Pharmaceuticals LLC | CV |
| 72673-031 | brivaracetam | solution | 10 mg/mL | Zhejiang Poly Pharm. Co., Ltd. | CV |
| 60505-4723 | Brivaracetam | tablet | 10 mg/1 | Apotex Corp. | CV |
| 60505-4727 | Brivaracetam | tablet | 100 mg/1 | Apotex Corp. | CV |
| 60505-4724 | Brivaracetam | tablet | 25 mg/1 | Apotex Corp. | CV |
| 60505-4725 | Brivaracetam | tablet | 50 mg/1 | Apotex Corp. | CV |
| 60505-4726 | Brivaracetam | tablet | 75 mg/1 | Apotex Corp. | CV |
| 50228-556 | brivaracetam | tablet, film coated | 10 mg/1 | ScieGen Pharmaceuticals, Inc. | CV |
| 70710-1584 | brivaracetam | tablet, film coated | 10 mg/1 | Zydus Pharmaceuticals USA Inc. | CV |
| 70771-1754 | brivaracetam | tablet, film coated | 10 mg/1 | Zydus Lifesciences Limited | CV |
| 72205-267 | brivaracetam | tablet, film coated | 10 mg/1 | Novadoz Pharmaceuticals LLC | CV |
| 73473-904 | brivaracetam | tablet, film coated | 10 mg/1 | Solaris Pharma Corporation | CV |
| 76282-822 | BRIVARACETAM | tablet, film coated | 10 mg/1 | Exelan Pharmaceuticals, Inc | CV |
| 84386-068 | Brivaracetam | tablet, film coated | 10 mg/1 | Aurobindo Pharma Limited | CV |
| 50228-560 | brivaracetam | tablet, film coated | 100 mg/1 | ScieGen Pharmaceuticals, Inc. | CV |
| 70710-1588 | brivaracetam | tablet, film coated | 100 mg/1 | Zydus Pharmaceuticals USA Inc. | CV |
| 70771-1758 | brivaracetam | tablet, film coated | 100 mg/1 | Zydus Lifesciences Limited | CV |
| 72205-271 | brivaracetam | tablet, film coated | 100 mg/1 | Novadoz Pharmaceuticals LLC | CV |
| 73190-077 | brivaracetam | tablet, film coated | 100 mg/1 | AvKARE | CV |
| 73473-908 | brivaracetam | tablet, film coated | 100 mg/1 | Solaris Pharma Corporation | CV |
| 76282-826 | BRIVARACETAM | tablet, film coated | 100 mg/1 | Exelan Pharmaceuticals, Inc | CV |
| 84386-072 | Brivaracetam | tablet, film coated | 100 mg/1 | Aurobindo Pharma Limited | CV |
| 50228-557 | brivaracetam | tablet, film coated | 25 mg/1 | ScieGen Pharmaceuticals, Inc. | CV |
| 70710-1585 | brivaracetam | tablet, film coated | 25 mg/1 | Zydus Pharmaceuticals USA Inc. | CV |
| 70771-1755 | brivaracetam | tablet, film coated | 25 mg/1 | Zydus Lifesciences Limited | CV |
| 72205-268 | brivaracetam | tablet, film coated | 25 mg/1 | Novadoz Pharmaceuticals LLC | CV |
Showing 40 of 62 listings.
Questions
Is brivaracetam a controlled substance?
Yes. Brivaracetam is a Schedule V controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Brivaracetam (Schedule V).
Is brivaracetam a narcotic?
No. The DEA list does not mark brivaracetam as a narcotic (NARC = N) and places it in Schedule V.
What schedule is brivaracetam?
Brivaracetam is Schedule V in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Brivaracetam
- What is Brivaracetam used for?FDA label uses
- Generic for BriviactFDA Orange Book
- What is Briviact used for?FDA label uses
- Is Briviact a controlled substance?Schedule V
- Brivaracetam Medicare Part D coverageBy plan and state
- NDC 50474-370Brivaracetam NDC record
- NDC 50474-470Brivaracetam NDC record
- NDC 50474-570Brivaracetam NDC record
- Schedule V drugs listDEA schedule